Digene Will Achieve Strategic Goals Faster Through Qiagen Merger, CEO Says

Human papillomavirus test maker Digene will expand its international presence and gain critical mass to help counter looming competition in the lucrative HPV test market by merging with Dutch molecular diagnostics firm Qiagen